Status:
RECRUITING
Generalization With AI Navigation Using StaRt
Lead Sponsor:
New York University
Collaborating Sponsors:
Syracuse University
Montclair State University
Conditions:
Speech Sound Disorder
Eligibility:
All Genders
9-17 years
Phase:
PHASE2
Brief Summary
Speech Sound Disorder (SSD) affects a significant portion of school-aged children, leading to social and emotional challenges that can persist into adolescence and adulthood. The number of productions...
Detailed Description
This study will measure the effects of AI-guided home practice as a follow-up to participation in a study of technology-enhanced treatment for speech sound disorder affecting the American English "r" ...
Eligibility Criteria
Inclusion
- • Must be between 9;0 and 17;11 (years;months) old at the time of enrollment.
- Must speak English as the dominant or equally dominant language
- Must have begun learning English by age 3, per parent report.
- Must hear a rhotic dialect of English from at least one speaker in the home if the home language is English.
- Must pass a pure-tone hearing screening.
- Must pass a brief examination of oral structure and function.
- Must demonstrate age-appropriate receptive and expressive language abilities on the Clinical Evaluation of Language Fundamentals-5 (CELF-5).
- Must have access to a laptop or desktop computer for study sessions.
- Must have home wifi sufficient to support video calls in the event of randomization to the telepractice condition.
- Must have completed participation in the VISIT randomized controlled trial.
- Must score at least 60% correct in at least one treatment session during the related previous study, VISIT.
Exclusion
- • Must not exhibit voice or fluency disorder of a severity judged likely to interfere with the ability to participate in study activities.
- Must not currently have orthodontia that crosses the palate and cannot be removed.
- Must not have history of permanent hearing loss.
- Must not have an existing diagnosis of developmental disability such as cerebral palsy or Down Syndrome.
- Must not have history of major brain injury, surgery, or stroke in the past year.
- Must not have epilepsy with active seizure incidents with in the past 6 months.
- Must not show clinically significant signs of apraxia of speech or dysarthria.
Key Trial Info
Start Date :
December 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06884943
Start Date
December 18 2024
End Date
July 1 2029
Last Update
June 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Montclair State University
Bloomfield, New Jersey, United States, 07003
2
Syracuse University
Syracuse, New York, United States, 13244